Team studies new use for pulmonary hypertension drug

December 15, 2022

An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.

Read More

Asthma study may point to potential new therapeutic approach

May 8, 2020

Matthew Stier, PhD, left, R. Stokes Peebles, MD, and colleagues are studying a factor involved in the movement of certain white blood cells from the bone marrow to the lungs. (photo by Anne Rayner)

Read More

Team explores diabetes drug’s ability to treat RSV infection

July 12, 2018

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

Read More

Team to study RSV’s role in asthma formation

July 21, 2016

Investigators in the Division of Allergy, Pulmonary and Critical Care Medicine recently received a $4.5 million Asthma and Allergic Diseases Cooperative Research Center (AADCRC) grant from the National Institutes of Allergy and Infectious Diseases (NIAID).

Read More